At Harmonex Neuroscience Research, patients are given the opportunity to try new treatments for their conditions. Some of these treatments are already FDA approved and are currently being used by doctors. However, pharmaceutical companies may find that certain medications are more effective in a different population than intended. When this happens the companies will request that clinical trials be conducted.

Clinical trials (also known as clinical research) are research studies in human volunteers that investigate treatments and observe patient performance with new treatments. They play an important role in developing new treatment options for a variety of diseases.

Before any new treatment can be tested in humans, it must have shown positive results in the laboratory and/or in animal studies. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.

The United States Food and Drug Administration (FDA) monitors most clinical trials to protect the participants and the general public. Ultimately, the FDA reviews and analyzes data from successful clinical trials to determine whether the experimental treatment should be approved for the treatment of a specific disease or disorder.

Clinical trials may be carried out using completely new treatment options or using treatments that are already available. Clinical trials are the safest and quickest way to confirm whether new treatments are truly beneficial for patients.

These treatment options and the doctor's visits are free. Harmonex study patients receive the highest level of care available and are monitored and evaluated at greater levels than most patients.

Study patients typically receive full health screenings, extensive lab work and cardiovascular assessments, medications, and doctor's visits; all at no cost to the patient.

Our research coordinators are fully trained in conducting and administering clinical trials. They have undergone extensive training in good clinical practice and thorough training in Harmonex Research standard operating procedures.

Currently Enrolling Clinical Trials:

Adolescent Autism Study

Harmonex is conducting a clinical trial for children and adolescents with Autism Disorder. Any male or female participants 13 to 17 years of age associated with Autistic Disorder are eligible to enroll in this study.

Adolescent Schizophrenia

Harmonex is conducting a clinical trial for children and adolescents with Schizophrenia. Male and female participants ages 12 - 17 are eligible for this study.

Adolescent Schizophrenia Study

Harmonex is conducting a clinical trial for adolescents with Schizophrenia. Any male or female participants 13 to 17 years of age with Schizophrenia are eligible to enroll in this study.

Adult Major Depression Study - Rapastinel as Adjunctive Therapy

Harmonex is conducting a clinical trial for adults with Major Depression. Any male or female participants 19 to 65 years of age with Major Depression are eligible to enroll in this study.

Pediatric ADHD Study

Harmonex is conducting a clinical trial for children with ADHD. Any male or female participants 4 or 5 years of age with ADHD are eligible to enroll in this study.

Pediatric and Adolescent ADHD Study

Harmonex is conducting a clinical trial for children and adolescents with ADHD. Any male or female participants 6 to 17 years of age with ADHD are eligible to enroll in this study.

Pediatric and Adolescent Bipolar Study

Harmonex is conducting a clinical trial for children and adolescents with Bipolar Disorder. Any male or female participants 10 to 17 years of age with Bipolar Disorder are eligible to enroll in this study.

Pediatric and Adolescent Major Depression

Harmonex is conducting a clinical trial for children and adolescents with Major Depression. Any male or female participants ages 7 - to 11 and male participants ages 11 to 17 with Major Depression are eligible for this study.

Pediatric and Adolescent Major Depression with Brief Psychosocial Intervention

Harmonex is conducting a clinical trial for children and adolescents with Major Depression. Any male or female participants 7 to 17 years of age with Major Depression are eligible to enroll in this study.